Covalent Partners’s BlueLinx BXC Stock Holding History
Bought
Maintained
Sold
Other funds holding BXC
AWW
PCM
FTCM
SPCP
GC
GJL
Covalent Partners's BXC Position: Q1 2018 in Review
Covalent Partners sold out of BlueLinx (BXC) in Q1 2018, closing a stake of 229,640 shares — an estimated $2.24M sold.
Covalent Partners first reported a position in BXC in Q4 2017 and held it in 1 quarter. The position peaked at $2.24M in Q4 2017. 61 funds tracked by Wall St. Rank hold BXC as of Q1 2018.
- Covalent Partners reported no remaining BlueLinx position as of Q1 2018 after selling out during the quarter.
- Covalent Partners sold 229,640 BlueLinx shares in Q1 2018, an estimated $2.24M.
- Covalent Partners first reported a position in BlueLinx in Q4 2017 and held it in 1 quarter.
- Covalent Partners's BlueLinx position peaked at $2.24M in Q4 2017.
- 61 funds tracked by Wall St. Rank held BlueLinx as of Q1 2018.
Based on Covalent Partners's 13F filing for Q1 2018, filed 15 May 2018.